Tobacco Mosaic Virus Replicase-Mediated Cross-Protection: Contributions of RNA and Protein-Derived Mechanisms  by Goregaoker, Sameer P. et al.
9Virology 273, 267–275 (2000)
doi:10.1006/viro.2000.0430, available online at http://www.idealibrary.com onTobacco Mosaic Virus Replicase-Mediated Cross-Protection:
Contributions of RNA and Protein-Derived Mechanisms
Sameer P. Goregaoker,* Lori G. Eckhardt,† and James N. Culver*,†,1
*Cell and Molecular Biology Program and †Center for Agricultural Biotechnology,
University of Maryland Biotechnology Institute, College Park, Maryland 20742
Received April 3, 2000; returned to the author for revision April 26, 2000; accepted May 18, 2000
Specific sequences of the tobacco mosaic virus (TMV) RNA-dependent RNA-polymerase (RdRp) gene were investigated for
their ability to confer cross-protection. Nine overlapping segments ranging from 713 to 1070 nucleotides in length and
covering the methyltransferase, helicase, and polymerase (POL) domains of the TMV RdRp open reading frame were
systemically expressed in Nicotiana benthamiana using a potato X virus (PVX) vector [Chapman, S., Kavanagh, T., and
Baulcombe, D. C. (1992). Plant J., 1, 549–557]. PVX-infected plants were subsequently challenge inoculated with 10 mg of
wild-type TMV and monitored for TMV accumulation. Mock inoculated plants and plants preinfected with the unmodified PVX
vector rapidly accumulated high levels of challenge virus. In contrast, plants preinfected with PVX vectors expressing
segments of the TMV RdRp open reading frame displayed either high or low levels of protection. High protection levels were
observed for PVX constructs expressing segments of the TMV POL domain, whereas low protection levels were observed
for PVX constructs expressing segments covering the methyltransferase and helicase domains. Frameshift mutations that
blocked protein expression from RdRp segments disrupted only the high levels of protection derived from POL segments and
not the low levels derived from the other segments. However, all RdRp segments conferred similarly high levels of protection
against a TMV construct with restricted local movement. Thus both RNA and protein sequences in conjunction with the speed
of the infecting challenge virus can affect the protection derived from the TMV RdRp gene. © 2000 Academic PressINTRODUCTION
Cross-protection, which is defined as the ability of one
virus to inhibit or prevent infection by a second virus, was
first observed by McKinney (1929). Since this description,
numerous studies have sought to provide understanding
of the mechanisms responsible for this phenomenon as
well as to develop its use for field applications (Sher-
wood, 1987). During the past two decades, transgenic
and viral vector technologies have permitted the explo-
ration of this phenomenon at the molecular level. From
these studies, several different viral and host processes
have been implicated in conferring protection. In general,
cross-protection derived from specific viral sequences
have been attributed to RNA- or protein-based mecha-
nisms. However, the collective contributions of these
different mechanisms to the observed protection have
not been fully explored.
Several lines of evidence indicate that RNA-based
protection is derived from a nucleotide sequence-spe-
cific host defense mechanism, termed posttranscrip-
tional gene silencing (PTGS), that targets viral RNAs for
destruction (Dougherty and Parks, 1995; Baulcombe,
1999). For example, Hamilton and Baulcombe (1999)
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267identified PTGS-associated RNA molecules that were
complementary to viral RNAs and accumulate only in the
presence of viral replication. In addition, Ratcliff et al.
(1999) used viral vectors to demonstrate that PTGS can
be activated to induce cross-protection by a diverse
group of RNA viruses. Furthermore, viral proteins, such
as the potyvirus HC-pro, act as suppressors of PTGS in
transgenic plants (Anandalakshmi et al., 1998; Beclin et
al., 1998; Brigneti et al., 1998; Kasschau and Carrington,
1998). Thus viruses have evolved specific countermea-
sures to suppress plant-derived PTGS. Taken together,
these findings demonstrate that PTGS is a common plant
defense response active against diverse viruses and
likely to play an important role in cross-protection.
Cross-protection derived from specific viral proteins
has also been demonstrated. One well-studied system
involves the ability of the tobacco mosaic virus (TMV)
coat protein to mediate cross-protection. Evidence for
the role of coat protein in conferring protection comes
from several sources (Bendahmane and Beachy, 1998).
In particular, the ability of unencapsidated viral RNA to
overcome the protection led Sherwood and Fulton (1982)
to speculate that cross-protection between TMV strains
was the result of the protecting virus blocking the disas-
sembly of the challenge virus. Subsequent TMV studies
have confirmed that coat protein-derived protection is
dependent on the ability of coat protein to properly as-
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268 GOREGAOKER, ECKHARDT, AND CULVERsociate with and block the disassembly of the challenge
virus (Bendahmane et al., 1997 and Lu et al., 1998). Other
forms of protein-derived protection that utilize defective
viral gene products have also been described. For in-
stance, the transgenic expression of a defective TMV
30-kDa cell-to-cell movement protein has been shown to
interfere in the movement of a broad spectrum of viruses
(Cooper et al., 1995). Thus it is clear from these examples
hat the preexpression of viral proteins also plays an
mportant role in cross-protection.
The TMV RNA-dependent RNA polymerase (RdRp)
ene encodes a 126-kDa protein that is terminated by a
ingle amber stop codon. Readthrough of this termina-
ion codon results in the production of a larger 183-kDa
rotein (Pelham, 1978). In addition, a subgenomic mRNA
erived from the readthrough portion of the 183-kDa
rotein and encoding a putative 54-kDa protein has also
een observed (Sulzinski et al., 1985). However, this
protein has not been detected in vivo (Sulzinski et al.,
1985; Golemboski et al., 1990). Homology comparisons
reveal the presence of methyltransferase (MT) and heli-
case (HEL) domains within the 126-kDa protein and a
polymerase (POL) domain within the readthrough, 54-
kDa portion of the 183-kDa protein (Koonin, 1991; Koonin
and Dolja, 1993; Buck, 1996).
The ability of a viral RdRp gene to mediate protection
was first described by Golemboski et al. (1990) in plants
transformed with the 54-kDa POL domain of the TMV
183-kDa protein. Subsequent studies have produced
conflicting reports regarding the mechanism(s) behind
this resistance. For example, transgenic plants that dis-
play silencing typically accumulate little transgene tran-
script. However, resistant 54-kDa plants accumulated
significant levels of the transgene transcript. In addition,
Carr et al. (1992) demonstrated that a nontranslatable
54-kDa open reading frame (ORF) failed to confer pro-
tection in a transient protoplast assay. These lines of
evidence suggest a protein-mediated mechanism is in-
volved in conferring resistance. However, Marano and
Baulcombe (1998) demonstrated that 54-kDa transgenic
plants were resistant against a potato virus X (PVX)
vector designed to express TMV 54-kDa gene se-
quences as small as 383 nucleotides. This finding is
consistent with an RNA-based PTGS mechanism. Re-
lated studies using the 54-kDa ORF of another tobamo-
virus, pepper mild mottle virus, also indicated that resis-
tance in this system was derived from an RNA-based
PTGS mechanism (Tenllado et al., 1996). In addition,
other portions of the TMV RdRp gene have been found to
confer protection when expressed as transgenes. Most
notably, Donson et al. (1993) produced transgenic plants
containing a 183-kDa RdRp gene disrupted by the inser-
tion of a bacterial transposon. Plants containing this
gene displayed resistance against several different to-
bamoviruses in a non-homology-dependent fashion. This
lack of specificity suggests the conferred resistance wasnot derived from a PTGS mechanism. Collectively, these
findings suggest that multiple mechanisms may contrib-
ute to the resistance conferred by TMV RdRp domains.
To further dissect the role of the TMV RdRp in cross-
protection, a PVX vector (Chapman et al., 1992) was used
to individually express nine overlapping segments com-
prising the entire TMV 183-kDa RdRp ORF. These plants
were subsequently challenged with TMV and monitored
for virus accumulation. Results demonstrated that all
nine RdRp segments conferred low levels of protection
that were independent of protein expression. However,
three segments covering the POL domain conferred sig-
nificantly higher levels of protection that were dependent
on protein expression. In contrast, no distinctions in the
levels of protection conferred by either RNA or protein
were observed when plants were challenge inoculated
with a TMV virus deficient in local movement. Thus the
effectiveness of the protection conferred by either RdRp
RNA or protein sequences is greatly influenced by the
speed of challenge virus infection.
RESULTS
Construction and expression of TMV RdRp segments
For this study, nine overlapping RdRp segments rang-
ing from 713 to 1070 nucleotides in length and covering
the entire 183-kDa TMV ORF were individually cloned
into the viral vector PVX2C2S (Fig. 1). Each segment was
engineered to contain its own translational start and stop
codons to permit protein expression from the PVX2C2S
vector. PVX2C2S constructs containing the different TMV
RdRp sequences produced mild mosaic symptoms in
Nicotiana benthamiana that were similar in appearance
to those produced by the unmodified PVX vector. Main-
tenance of each TMV RdRp segment within the PVX
vector was confirmed by RT–PCR analysis of viral RNA
isolated from systemically infected tissue. PCR analysis
using TMV segment-specific primers indicated that each
RdRp segment was maintained within the PVX vector
(Fig. 2A). In addition, PCR analysis using PVX-specific
primers that flank the insert also confirmed the mainte-
nance of the TMV RdRp segments (data not shown).
However, on occasion several faint smaller bands were
also observed, indicating that a small proportion of the
PVX population had deleted all or part of the TMV RdRp
insert. To prevent the buildup of PVX populations that
lack TMV RdRp sequences, only transcript RNA derived
from the cDNA clones was used as inoculum in this
study.
Hexa-histidine tags were engineered at the amino-
terminus of each TMV RdRp segment to allow protein
expression from PVX vector constructs to be monitored.
Western immunoblot analysis demonstrated that seg-
ments 1–5, 7, and 8 accumulated detectable levels of
protein in systemically infected leaf tissue (Fig. 2B). In
contrast, this method failed to detect protein from seg-
p domains (A) and the locations of the nine expressed TMV RdRp segments
(
269TMV RdRp-DERIVED PROTECTIONments 6 and 9. Western immunoblot results were also
variable with respect to the band intensity and substrate
incubation time needed to observe the tagged segments.
Variations in protein accumulation likely represent differ-
ences in the translation and/or stability of each RdRp
segment.
Protection conferred by individual TMV RdRp
segments
TMV challenge inoculations of N. benthamiana plants
either mock inoculated or inoculated with the unmodified
PVX vector or a vector construct containing 850 nucleo-
tides of the Escherichia coli CpdB gene resulted in the
rapid accumulation of TMV in inoculated leaves (Fig. 3).
These plants also displayed severe necrosis at the local
and systemic level that prevented sampling beyond 4
days postinoculation (d.p.i.). In contrast, all nine PVX
constructs expressing segments of the TMV RdRp ORF
resulted in significantly lower accumulations of chal-
lenge TMV at 2 and 4 d.p.i. However, at 6 d.p.i., PVX
vector constructs containing TMV RdRp segments 1–6,
FIG. 1. Schematic representation of the TMV genome including RdR
B). TMV nucleotide number is from Goelet et al. (1982).covering the 126-kDa MT and HEL domains, showed
significant increases in the accumulation of TMV. At wFIG. 2. PVX2C2S maintenance and expression of TMV RdRp seg-
ments. (A) RT–PCR amplification of TMV RdRp segments from total RNA
purified from N. benthamiana leaves systemically infected with
PVX2C2S constructs containing RdRp segments 1–9. (B) Western im-
munoblot detection of hexa-histidine tagged TMV RdRp proteins de-
rived from segments 1–5, 7, and 8. Approximately 30 mg of total protein





270 GOREGAOKER, ECKHARDT, AND CULVER8 d.p.i., plants protected by segments 1–6 showed accu-
mulations of TMV that were too high to measure via local
lesion assay. Although not as severe as in control plants,
increased TMV accumulations in these plants was ac-
companied by the appearance of TMV-induced chlorosis
and necrosis in both inoculated and noninoculated tis-
sues.
FIG. 3. The accumulation of challenge TMV over time in the inocu-
lated leaves of plants preinfected with PVX2C2S-TMV RdRp constructs.
Samples were collected at 2, 4, 6, 8, and 10 d.p.i. with 10 mg of purified
TMV. TMV accumulations were determined by local lesion assay on N.
tabacum cv Xanthi nc. Bars represent the average 6 SE of TMV lesion
umbers obtained from 6–12 individual plants preinfected with
VX2C2S constructs and challenge inoculated with TMV. X indicates
MV accumulations too numerous to count and/or TMV-induced death
f challenge-inoculated leaves with no further samples taken.Three PVX-expressed TMV RdRp segments, 7–9, con-
ferred significantly greater delays in the accumulation ofchallenge TMV (Fig. 3). These three segments cover the
54-kDa readthrough portion of the TMV RdRp ORF and
contain elements of the POL domain. Of these three
segments, 7 and 9 conferred delays in the accumulation
of challenge TMV that lasted the entire 10-day sampling
period, whereas the delay conferred by segment 8 lasted
only 8 d.p.i. In addition, by 10 d.p.i., sporadic areas of
TMV- induced chlorosis and necrosis were observed in
the noninoculated tissue of plants preinfected with
PVX2C2S constructs expressing segments 7–9, indicat-
ing that systemic TMV movement had occurred.
Effect of frameshift mutations on TMV RdRp
conferred protection
Frameshift mutations were created in segments 1, 3, 4,
and 6–9 to determine whether the observed protection
was associated with the expression of the correspond-
ing protein. These mutations were designed to shift the
normal reading frame of each RdRp segment at a spe-
cific amino acid downstream of the engineered transla-
tional start codon. Each frameshift leads to a new stop
codon, resulting in a severely truncated protein. The
locations of these frameshifts relative to the start codon
of each segment are amino acid position 11 for seg-
ments 1, 6, 8 and 9; position 13 for segment 3; position 58
for segment 7; and position 62 for segment 4.
Cross-protection results obtained from frameshift seg-
ments revealed no significant alteration in the level of
protection conferred by segments 1, 3, 4, and 6 (Fig. 4).
Thus the expression of protein from these RdRp seg-
ments is not required to provide low levels of protection
against challenge TMV. In contrast, frameshift mutations
significantly affected the high levels of protection con-
ferred by segments 7–9 (Fig. 4). This finding indicates
that protein expression from these segments is a key
factor in their ability to confer high levels of protection.
However, frameshift segments 7–9 did confer low levels
FIG. 4. Accumulation of challenge TMV in the inoculated leaves of
plants preinfected with PVX2C2S-TMV RdRp and RdRp–frameshift (FS)
constructs. Samples were collected at 6 d.p.i., and TMV accumulations
were determined as described previously. Bars represent the aver-
age 6 SE of TMV lesion numbers obtained from four to six individual





271TMV RdRp-DERIVED PROTECTIONof protection similar to the protection levels conferred by
segments 1–6.
Specificity of the conferred protection
The specificity of the protection conferred by TMV
RdRp segments 1, 3, and 5–9 was investigated using the
tobamovirus tobacco mild green mosaic virus (TMGMV-
U2) as challenge inoculum. TMGMV-U2 shares approxi-
mately 76% overall homology with TMV. Results demon-
strated that all PVX-expressed TMV RdRp segments al-
lowed the rapid accumulation of TMGMV-U2 within 4
days postchallenge inoculation (d.p.i.) (data not shown).
The rapid accumulation of TMGMV-U2 was also accom-
panied by severe necrosis in both inoculated and non-
inoculated tissues. Thus none of the tested TMV RdRp
segments were capable of conferring protection against
the related tobamovirus TMGMV-U2.
Challenge inoculations with TMV-GFP
To determine whether the protection conferred by PVX
expressed TMV RdRp segments was the result of re-
duced numbers of infection sites and/or reductions in
virus spread, N. benthamiana leaves systemically in-
fected with PVX constructs expressing TMV RdRp seg-
ments 1, 2, 4–9, and 9-frameshift were challenge inocu-
FIG. 5. TMV30BGFP challenge inoculations. (A) Number of fluoresce
reinfected with PVX2C2S constructs containing TMV RdRp segments 1
bserved on 5–12 challenge-inoculated leaves. (B) Representative TM
nmodified PVX2C2S vector, or 2, 3, and 4, PVX2C2S constructs contain
t 8 d.p.i. with TMV30BGFP at 53 magnification.lated with 10 mg of TMV30BGFP. This TMV construct
expresses the green fluorescent protein (GFP) from Ae-quorea victoria downstream of the CP subgenomic pro-
moter (Shivprasad et al., 1999). Challenge-inoculated
leaves were examined by fluorescence microscopy to
determine the number and size of TMV30BGFP infection
sites. Leaves preinfected with PVX constructs express-
ing any of the TMV RdRp segments showed significantly
fewer TMV30BGFP infection sites compared with control
leaves infected with the unmodified PVX vector (Fig. 5A).
In addition, the few infection sites observed were smaller
in appearance and more restricted in their expansion
than infection sites found on control leaves (Fig. 5B).
Furthermore, GFP fluorescence was not observed in
systemic nonchallenged tissue of plants preinfected with
PVX2C2S TMV RdRp constructs, indicating that
TMV30BGFP did not move systemically. These findings
indicate that all TMV RdRp segments confer equally high
levels of protection against TMV30BGFP.
DISCUSSION
Cross-protection can be mediated by both viral RNA,
as is the case for PTGS, or viral proteins, as is the case
for coat protein-mediated protection (Ratcliff et al., 1999;
Bendahmane et al., 1997; and Lu et al., 1998). Thus
depending on the system, different and sometimes mul-
tiple mechanisms may contribute to the protection phe-
30BGFP infection sites observed at 8 d.p.i. on N. benthamiana leaves
nd 9frameshift (FS). Bars represent the average 6 SE of infection sites
FP infection sites on leaves systemically infected with either 1, the
V RdRp segments 6, 9, and 9-FS, respectively. Photographs were takennt TMV
, 3–9, a
V30BGnomenon. In this study, the viral vector PVX2C2S was
used to determine the ability of different TMV RdRp
272 GOREGAOKER, ECKHARDT, AND CULVERdomains to confer cross-protection. By using this strat-
egy, specific features of the TMV RdRp, such as individ-
ual domains or the ability to express protein, can be
assessed and compared for their role in providing pro-
tection. The identification of RdRp features that confer
protection should provide insight into the mechanisms
responsible for this phenomenon.
Cross-protection assays using the PVX2C2S system
revealed two distinct levels of protection. TMV segments
covering the 126-kDa ORF including MT and HEL do-
mains all conferred a similar 2-day delay in the accumu-
lation of challenge TMV, whereas segments 7–9, cover-
ing elements of the 54-kDa POL domain, conferred sig-
nificantly higher levels of protection. However, in all
cases the protection was incomplete and challenge TMV
could eventually be recovered from both inoculated and
noninoculated tissues. The ability of the challenge virus
to establish initial infection sites may reflect the inability
of the PVX2C2S vector to uniformly infect all leaf cells
(Chapman et al., 1992; Baulcombe et al., 1995). Cells not
infected by the PVX2C2S RdRp constructs presumably
remain susceptible to TMV, providing replication sites
that ultimately lead to the breakdown of protection. In
addition, both low and high levels of protection were not
effective against the related tobamovirus TMGMV-U2.
The specificity of this protection is consistent with results
previously obtained from the transgenic expression of
the TMV 54-kDa ORF (Golemboski et al., 1990) and sug-
gests an underlying homology-dependent mechanism.
Frameshift mutations engineered into specific RdRp
segments demonstrated that protein translation was re-
quired to maintain the high levels of protection derived
from the POL domain but not the lower protection levels
derived from the other RdRp segments. Similarly,(Carr et
al. (1992) demonstrated that a nontranslatable TMV 54-
kDa ORF did not confer protection in a transient expres-
sion system. This suggests that translation of the 54-kDa
POL domain plays an important role in conferring pro-
tection. In contrast, frameshift mutations did not affect
the low level of protection conferred by RdRp segments
covering the 126-kDa ORF, indicating that this level of
resistance was RNA mediated. Furthermore, frameshift
constructs 7–9, covering the 54-kDa ORF, conferred a
2-day delay in TMV accumulation that was similar to the
delay conferred by RdRp segments covering the 126-kDa
ORF (Fig. 4). Thus the RNA sequences of the POL domain
are also capable of conferring low protection levels.
The TMV POL domain was divided into three overlap-
ping segments, all of which conferred significant levels
of protection, with the highest levels being obtained from
segments 7 and 9 (Fig. 3). However, no correlation was
observed between the level of protein accumulation and
the level of protection. In particular, protein derived from
segments 7 and 8 were readily detected by Western
immunoblotting, whereas repeated attempts to detect
the accumulation of segment 9 failed. However, frame-shift studies indicate that translation of the segment 9
protein is required to obtain the high level of protection.
Thus the hexa-histidine tag on segment 9 may be unsta-
ble or the protein itself may be sequestered within the
host in some fashion that prevents its detection. Our
failure to detect segment 9 is reflected in the inability of
previous studies to detect the TMV 54-kDa RdRp protein
in either virus-infected or transgenic plants (Sulzinski et
al., 1985; Golemboski et al., 1990).
The simplest explanation for these data are that the
polypeptides derived from TMV 54-kDa POL segments
function in a dominant-negative fashion to disrupt chal-
lenge virus infection. Segment 7 covers the N-terminal
unique region of the POL as well as elements of the
fingers domain. Segment 9 covers the carboxyl half of
the POL, including the palm, thumb, and the carboxyl end
of the fingers domains. Segment 8 overlaps significantly
with segments 7 and 9 and contains the fingers and palm
domains. Structure and function comparisons with simi-
lar elements in other polymerases indicate that several
of these features are directly involved in RNA template
binding (Buck, 1996; O’Reilly and Kao, 1998). Interestingly,
Nguyen et al. (1996) demonstrated that viral RNA traffick-
ing within transgenic 54-kDa plants was inhibited. Thus
nonproductive interactions between truncated POL pro-
teins and the challenge virus RNA could explain the
mechanism of protection as well as account for its spec-
ificity.
An alternative explanation for these data are that
translation of the POL segments enhances the ability of
the RNA sequences to confer protection. Marano and
Baulcombe (1998) determined that the resistance ob-
served in 54-kDa transgenic plants was active against a
specific antisense region of the TMV POL domain and
occurred in a fashion that suggested a gene silencing-
like mechanism. In addition, Lewandowski and Dawson
(1998) observed that TMV POL sequences inhibit the
replication of truncated TMV RNAs by the wild-type virus.
Thus POL domain sequences appear to play a critical
role in controlling TMV replication. Precisely how these
sequences modulate virus replication and whether this
process contributes to the observed protection via a
protein- and/or RNA-based mechanism remain to be
determined.
TMV30BGFP inoculations demonstrated that the
RdRp-derived protection significantly blocked challenge
virus infection and spread (Fig. 5). The inability of
TMV30BGFP to establish an infection or to travel system-
ically in N. benthamiana plants displaying virus-induced
PTGS has been previously observed (Ratcliff et al., 1999).
Interestingly, no significant difference was observed in
the appearance or number of TMV30BGFP infection sites
on plants protected by RdRp segments that conferred
either high or low levels of protection against wild-type
TMV (Fig. 5). The ability of all TMV RdRp segments to
confer high protection levels against TMV30BGFP but
T273TMV RdRp-DERIVED PROTECTIONnot against wild-type TMV suggests that the RNA mech-
anism is considerably more effective against
TMV30BGFP than against the wild-type virus. We spec-
ulate that the variation in protection levels conferred
against TMV30BGFP and wild-type TMV reflects differ-
ences in the speed at which these viruses spread in the
inoculated leaf. Local lesion comparisons between
TMV30BGFP and wild-type TMV demonstrate that
TMV30BGFP is restricted in its ability to spread in a
cell-to-cell manner (Fig. 6). This is consistent with previ-
ous studies that show insertion of gene sequences
within the 39 end of TMV dramatically reduce the accu-
mulation of the 30-kDa cell-to-cell movement protein
(Culver et al., 1993). The reduced spread of TMV30BGFP
likely renders it more susceptible to the protection me-
diated by the RdRp RNA. In contrast, the wild-type virus
apparently moves/replicates with sufficient speed to al-
low it to rapidly overcome the RNA-mediated mecha-
nism. Whether the ability of wild-type TMV to overcome
this protection is due solely to its speed of movement or
is linked to the production of a suppressor of the RNA-
mediated protection remains to be investigated.
In summary, the protection conferred by segments of
the TMV RdRp gene expressed from within a heterolo-
gous viral vector can be attributed to at least two differ-
ent mechanisms. The first involves an RNA-mediated
FIG. 6. Half-leaf assays showing the local movement of wild-type
MV in comparison with TMV30BGFP on the local lesion host N.
tabacum cv. Xanthi nc. Photograph was taken 4 d.p.i. Arrows denote
individual lesions.mechanism that is apparently activated by the presence
of any RdRp gene sequence. In fact, the ability of anontranslatable TMV coat protein ORF to confer a similar
2-day delay in the accumulation of challenge TMV when
expressed from the PVX2C2S vector suggests that any
TMV sequence can function to activate this form of pro-
tection (Culver, 1996). Furthermore, the nucleotide-spe-
cific nature of this protection suggests the presence of a
PTGS-like mechanism. In addition, the levels of protec-
tion conferred by the RNA-based mechanism varied de-
pending on the movement speed of the challenge virus.
Rapid infection speeds have been proposed as a possi-
ble counterdefense strategy used by viruses to over-
come PTGS (Ratcliff et al., 1999). The second mechanism
of protection required protein expression from segments
of the POL domain and conferred substantially greater
delays in the accumulation of challenge TMV in compar-
ison with the RNA-based mechanism. However, the pro-
tein-mediated protection occurs in conjunction with the
RNA-mediated protection. It is feasible that the protein-
mediated mechanism functions only to slow wild-type
virus replication to a level that allows the RNA-derived
mechanism to be more effective. This type of combined
effect could also explain the homology-dependent nature
of the observed protection. However, additional studies
will be needed to determine whether these two mecha-
nisms actually cocontribute to produce an increased
level of protection.
MATERIALS AND METHODS
Virus constructs and expression analysis
pPVX2C2S contains the cloning sites EcoRV and SalI
engineered downstream of the PVX coat protein sub-
genomic promoter, allowing the transcription and trans-
lation of any inserted ORF (Chapman et al., 1992), Linker
modification at the EcoRV site was done to incorporate a
novel start codon followed by 6 histidine codons. This
modification results in the addition of a hexa-histidine
tag at the amino-terminus of any ORF cloned into the
pPVX2C2S vector.
Nine overlapping segments of the TMV 183-kDa RdRp
ORF were individually amplified using the polymerase
chain reaction (PCR) (Fig. 1; Culver, 1996). The 59 PCR
primers encoded EcoRV restrictions sites and were de-
signed to maintain the reading frames of each TMV RdRp
segment. The 39 PCR primers included a translational
stop codon and an SalI restriction site. The presence of
each TMV RdRp sequence within the PVX vector was
confirmed by DNA sequencing. To disrupt protein ex-
pression, frameshift mutations were also introduced into
TMV RdRp segments 1, 3, 4, and 6–9. These mutations
were created either by PCR mutagenesis (Higuchi et al.,
1988) or through the direct incorporation of frameshift
mutations into the 59 PCR primers used to amplify the
segments. Each frameshift mutation would result in the
severe truncation of the protein segment.




























274 GOREGAOKER, ECKHARDT, AND CULVERPVX vector construct and used to inoculate leaves of N.
enthamiana. At 10–14 d.p.i., systemically infected N.
enthamiana tissue displaying mild mosaic symptoms
as harvested, and total protein or RNA was extracted
Laemmli, 1970; Qiagen Inc., Valencia, CA). The extracted
roteins were resolved by SDS–PAGE and electroblotted
nto nitrocellulose paper. Monoclonal antibody specific
o hexa-histidine tracts (Sigma Chemical Co., St. Louis,
O) was used to visualize RdRp segments. Predicted
rotein products derived from TMV RdRp segments
hould range between 26 and 45 kDa in size. Extracted
NA was subjected to RT–PCR analysis using primers
pecific to each TMV RdRp segment.
ross-protection assays
Infectious transcripts from PVX TMV–RdRp constructs
ere used to inoculate N. benthamiana plants at the
hree- to five-leaf stage. Additional plants either mock
noculated or inoculated with the unmodified PVX vector
r a vector construct containing 850 nucleotides of the
pdB phosphodiesterase gene from E. coli were used as
ontrols. All plants were maintained in environmental
rowth chambers at 25°C under a 12-h photoperiod. The
irst two leaves of each plant to fully show systemic PVX
ymptoms were dusted with Carborundum. Each leaf
two per plant) was challenge inoculated with 5 mg of
urified TMV (Gooding and Hiebert, 1967) in 50 ml of 10
mM sodium phosphate buffer, pH 7.4. A 1-cm-diameter
leaf punch was taken from each of the two challenge
inoculated leaves at 2, 4, 6, 8, and 10 d.p.i. To determine
the accumulation of challenge TMV, leaf punches were
macerated in 200 ml of 10 mM phosphate buffer, pH 7.4,
and 50 ml was used to inoculate a Carborundum-dusted
eaf of Nicotiana tabacum cv. Xanthi nc, a local lesion
host for TMV but not for PVX. Each macerated sample
was similarly assayed two or three times, and the aver-
age lesion number was used to represent the accumu-
lation of TMV in that sample. Similar cross-protection
assays were performed using purified TMGMV-U2 as
challenge inoculum. In addition, PVX2C2S constructs ex-
pressing regions of the TMV RdRp involved in the elici-
tation of the N gene hypersensitive response (Erickson
t al., 1999) did not induce lesion formation when inoc-
lated by themselves onto leaves of N. tabacum cv.
Xanthi nc. Thus PVX2C2S RdRp constructs did not affect
the local lesion assays.
pTMV30BGFP contains the GFP ORF inserted down-
stream of the TMV coat protein subgenomic promoter
(Shivprasad et al., 1999). Purified TMV30BGFP virus (10
mg) was used to challenge inoculate N. benthamiana
leaves systemically infected with PVX2C2S constructs
expressing TMV RdRp segments. At 8 d.p.i., TMV30BGFP
infections sites were visualized and counted by fluores-
cence microscopy.ACKNOWLEDGMENTS
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